Virometix AG
8952 Schlieren, Wagistrasse 14
+41 (0)43 433 86 60
info@virometix.com
Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.
Virometix AG
Wagistrasse 14
8952 Schlieren
1 Ergebnisse für "immunotherapeutics" unter Virometix AG
Virometix | New Generation Vaccines - Novel Immunotherapeutics - Bi...
... Virometix | New Generation Vaccines - Novel Immunotherapeutics - Biotechnology - Switzerland ☰ Menu ... Virometix | New Generation Vaccines - Novel Immunotherapeutics - Biotechnology - Switzerland ... Virometix | New Generation Vaccines - Novel Immunotherapeutics - Biotechnology - Switzerland ...
Neurimmune Therapeutics AG
8952 Schlieren, Wagistrasse 18
+41 44 755 46 46
info@neurimmune.com
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.
Neurimmune Therapeutics AG
Wagistrasse 18
8952 Schlieren
4 Ergebnisse für "immunotherapeutics" unter Neurimmune Therapeutics AG
Neurimmune - About Neurimmune
... the development of immunotherapeutics for the treatment and prevention of human disorders with high ... investing our income into the development of efficacious immunotherapeutics designed to serve patients in ... immunotherapeutics for the treatment and prevention of human disorders with high unmet medical needs. With its unique ... immunotherapeutics designed to serve patients in need for better, safer, life-saving medicines.» Roger Nitsch, MD ...
ETH Zürich - Numerische Materialmodellierung
8005 Zürich, Technoparkstrasse 1 / Einstein PFA G 11 (2. OG)
ETH Zürich - Numerische Materialmodellierung
Technoparkstrasse 1
8005 Zürich
5 Ergebnisse für "immunotherapeutics" unter ETH Zürich - Numerische Materialmodellierung
Research – Laboratory for Systems and Synthetic Immunology | ETH Zurich
... ., cloning and protein expression, hybridoma, in vitro display screening) have transformed immunotherapeutics ... -generation immunotherapeutics, vaccines, and diagnostics. by Jennifer Cham, EMBL-EBI, Cambridge, UK ... display screening) have transformed immunotherapeutics (e.g., vaccines and antibodies) over the past 30 ... serve as a basis for the development of next-generation immunotherapeutics, vaccines, and diagnostics ...
Infozentrum: Catalog
... 2022 Classification Immunotherapeutics 2022 Immunotherapeutics Classification Publisher Membrane ... Chemistry and Structural Biology Immunotherapeutics 2022 554 E e-Book Donev Rossen Advances in Protein ... Chemistry and Structural Biology Immunotherapeutics Classification Life Sciences Biochemistry Biomolecules ...
ETH Zürich - Feasibility Lab
Technoparkstrasse 1
8005 Zürich
8 Ergebnisse für "immunotherapeutics" unter ETH Zürich - Feasibility Lab
Research – Laboratory for Systems and Synthetic Immunology | ETH Zurich
... ., cloning and protein expression, hybridoma, in vitro display screening) have transformed immunotherapeutics ... -generation immunotherapeutics, vaccines, and diagnostics. by Jennifer Cham, EMBL-EBI, Cambridge, UK ... expression, hybridoma, in vitro display screening) have transformed immunotherapeutics (e.g., vaccines and ... engineering immunity will also serve as a basis for the development of next-generation immunotherapeutics ...
Infozentrum: Catalog
... a complete search of all media available, please use Swisscovery . Search term Immunotherapeutics ... 2022 Immunotherapeutics Classification Publisher Membrane proteins Membrane proteins Publisher 2021 ... Location e-Book Donev Rossen Advances in Protein Chemistry and Structural Biology Immunotherapeutics 2022 ... 554 E e-Book Donev Rossen Advances in Protein Chemistry and Structural Biology Immunotherapeutics ...
ImmunOs Therapeutics AG
http://immunostherapeutics.com/
8952 Schlieren, Wagistrasse 14
ImmunOs Therapeutics AG is a clinical-stage biotechnology company developing the next generation of novel immunotherapies that enhance the efficacy of market leading checkpoint inhibitors and costimulatory agonists for cancer therapy. The company is actively discussing and exploring new strategic collaborations with leading global pharmaceutical companies.
ImmunOs Therapeutics AG
Wagistrasse 14
8952 Schlieren
7 Ergebnisse für "immunotherapeutics" unter ImmunOs Therapeutics AG
Company
... the field of drug delivery systems, protein engineering, immunotherapeutics discovery and pre-clinical ... of drug delivery systems, protein engineering, immunotherapeutics discovery and pre-clinical ...
Scientific Advisory Board - Immunostherapy
... biorepository for the melanoma and immunotherapeutics service at MSK. ULF PETRAUSCH, MD SCIENTIFIC ADVISOR Show ... immunotherapeutics service at MSK. ULF PETRAUSCH, MD SCIENTIFIC ADVISOR Show/hide Vita Dr. Ulf Petrausch is head of ...
InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
3 Ergebnisse für "immunotherapeutics" unter InSphero AG
... immunotherapeutics in physiologically relevant 3D tumor microtissues. Our 3D experts can build complex tumor spheroid ... enhancement of immune cell infiltration following treatment with immunotherapeutics, or the intrinsic ... immunotherapeutics in physiologically relevant 3D tumor microtissues. Our 3D experts can build complex tumor spheroid ... enhancement of immune cell infiltration following treatment with immunotherapeutics, or the intrinsic ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
1 Ergebnisse für "immunotherapeutics" unter ETH Entrepreneurship
4th Retreat 2015 – Interdisciplinary PhD Program Systems Biology | ...
... immunotherapeutics. In addition to hearing about the present state of science, students also spent some time thinking ... biology, working towards novel immunotherapeutics. In addition to hearing about the present state of ...
TECHNOPARK Winterthur AG
http://www.technopark-winterthur.ch
8406 Winterthur, Technoparkstrasse 2 / Trakt B, EG, Empfang
+41 58 934 75 30
info@tpw.ch
Wo Startups abheben
TECHNOPARK Winterthur AG
Technoparkstrasse 2
8406 Winterthur
1 Ergebnisse für "immunotherapeutics" unter TECHNOPARK Winterthur AG
PowerPoint-Präsentation
... Immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases ... Immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
11 Ergebnisse für "immunotherapeutics" unter University of Zurich
Publication list SIAF 2012
... & Immunotherapeutics, 8(10):1485-1491. Ballow, Mark; Akdis, Cezmi A; Casale, Thomas B; Wardlaw, Andrew J; Wenzel, Sally ... & Immunotherapeutics, 8(10):1485-1491. Ballow, Mark; Akdis, Cezmi A; Casale, Thomas B; Wardlaw, Andrew J; Wenzel, Sally ...
RAV Regionales Arbeitsvermittlungszentrum Winterthur
8401 Winterthur, Technoparkstrasse 2 / Trakt B, 1. OG
+41 43 259 67 00
hotline.ravwinterthur@vd.zh.ch
Regionales Arbeitsvermittlungszentrum
RAV Regionales Arbeitsvermittlungszentrum Winterthur
Technoparkstrasse 2
8401 Winterthur